Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Alan Schatzberg

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Living Beings

Saimiri

Procedures

Double-Blind Method

Anatomy

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Bailey Steffani R; Harrison Christopher T; Jeffery Christina J; Ammerman Seth; Bryson Susan W; Killen Diana T; Robinson Thomas N; Schatzberg Alan F; Killen Joel D
Withdrawal symptoms over time among adolescents in a smoking cessation intervention: do symptoms vary by level of nicotine dependence?
Schatzberg Alan F
Response to the presidential address.
Gomez Rowena G; Posener Joel A; Keller Jennifer; DeBattista Charles; Solvason Brent; Schatzberg Alan F
Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Alan Schatzberg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Bailey Steffani R; Harrison Christopher T; Jeffery Christina J; Ammerman Seth; Bryson Susan W; Killen Diana T; Robinson Thomas N; Schatzberg Alan F; Killen Joel D
Withdrawal symptoms over time among adolescents in a smoking cessation intervention: do symptoms vary by level of nicotine dependence?
Addictive behaviors 2009;34(12):1017-22.
2009: Schatzberg Alan F
Response to the presidential address.
The American journal of psychiatry 2009;166(10):1105-7.
2009: Gomez Rowena G; Posener Joel A; Keller Jennifer; DeBattista Charles; Solvason Brent; Schatzberg Alan F
Effects of major depression diagnosis and cortisol levels on indices of neurocognitive function.
Psychoneuroendocrinology 2009;34(7):1012-8.
2009: Kupfer David J; Schatzberg Alan F; Grochocinski Victoria J; Dunn Leslie O; Kelley Katherine A; O'Hara Ruth M
The Career Development Institute for Psychiatry: an innovative, longitudinal program for physician-scientists.
Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry 2009;33(4):313-8.
2009: Reaven Gerald M; Lieberman Jeffrey A; Sethuraman Gopalan; Kraemer Helena; Davis John M; Blasey Christine; Tsuang Ming T; Schatzberg Alan F
In search of moderators and mediators of hyperglycemia with atypical antipsychotic treatment.
Journal of psychiatric research 2009;43(11):997-1002.
2009: Reynolds Charles F; Lewis David A; Detre Thomas; Schatzberg Alan F; Kupfer David J
The future of psychiatry as clinical neuroscience.
Academic medicine : journal of the Association of American Medical Colleges 2009;84(4):446-50.
2009: Schatzberg Alan F
The silver lining of recent effectiveness trials.
World psychiatry : official journal of the World Psychiatric Association (WPA) 2009;8(1):30-2.
2009: Perahia David G S; Quail Deborah; Desaiah Durisala; Montejo Angel L; Schatzberg Alan F
Switching to duloxetine in selective serotonin reuptake inhibitor non- and partial-responders: effects on painful physical symptoms of depression.
Journal of psychiatric research 2009;43(5):512-8.
2009: Lyons David M; Parker Karen J; Katz Maor; Schatzberg Alan F
Developmental cascades linking stress inoculation, arousal regulation, and resilience.
Frontiers in behavioral neuroscience 2009;3():32.
2009: Amsterdam Jay D; Williams David; Michelson David; Adler Lenard A; Dunner David L; Nierenberg Andrew A; Reimherr Frederick W; Schatzberg Alan F
Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
Neuropsychobiology 2009;59(4):227-33.
2009: Katz Maor; Liu Chunlei; Schaer Marie; Parker Karen J; Ottet Marie-Christine; Epps Averi; Buckmaster Christine L; Bammer Roland; Moseley Michael E; Schatzberg Alan F; Eliez Stephan; Lyons David M
Prefrontal plasticity and stress inoculation-induced resilience.
Developmental neuroscience 2009;31(4):293-9.
2008: Killen Joel D; Fortmann Stephen P; Schatzberg Alan F; Arredondo Christina; Murphy Greer; Hayward Chris; Celio Maria; Cromp Deann; Fong Dalea; Pandurangi Maya
Extended cognitive behavior therapy for cigarette smoking cessation.
Addiction (Abingdon, England) 2008;103(8):1381-90.
2008: Keller Jennifer; Shen Lin; Gomez Rowena G; Garrett Amy; Solvason H Brent; Reiss Allan; Schatzberg Alan F
Hippocampal and amygdalar volumes in psychotic and nonpsychotic unipolar depression.
The American journal of psychiatry 2008;165(7):872-80.
2008: Buckley Theresa; Duggal Vandana; Schatzberg Alan F
The acute and post-discontinuation effects of a glucocorticoid receptor (GR) antagonist probe on sleep and the HPA axis in chronic insomnia: a pilot study.
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2008;4(3):235-41.
2008: Schatzberg Alan F
Achieving remission and favorable outcomes in patients with depression/anxiety and substance use disorders.
CNS spectrums 2008;13(4 Suppl 6):10-2.
2008: Schatzberg Alan F; Weiss Roger D; Brady Kathleen T; Culpepper Larry
Bridging the clinical gap: managing patients with co-occurring mood, anxiety, and alcohol use disorders. Introduction.
CNS spectrums 2008;13(4 Suppl 6):3.
2008: Schatzberg Alan F; Lindley Steven
Glucocorticoid antagonists in neuropsychiatric [corrected] disorders.
European journal of pharmacology 2008;583(2-3):358-64.
2008: Trivedi Madhukar H; Kocsis James H; Thase Michael E; Morris David W; Wisniewski Stephen R; Leon Andrew C; Gelenberg Alan J; Klein Daniel N; Niederehe George; Schatzberg Alan F; Ninan Philip T; Keller Martin B
REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design.
Psychopharmacology bulletin 2008;41(4):5-33.
2007: Sartorius Norman; Baghai Thomas C; Baldwin David S; Barrett Barbara; Brand Ursula; Fleischhacker Wolfgang; Goodwin Guy; Grunze Heinz; Knapp Martin; Leonard Brian E; Lieberman Jeffrey; Nakane Yoshibumi; Pinder Roger M; Schatzberg Alan F; Svestka Jaromír; Baumann Pierre; Ghalib Kareem; Markowitz John C; Padberg Frank; Fink Max; Furukawa Toshiaki; Fountoulakis Konstantinos N; Jensen Peter; Kanba Shigenobu; Riecher-Rössler Anita
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10 Suppl 1():S1-207.
2007: Karssen A M; Her S; Li J Z; Patel P D; Meng F; Bunney W E; Jones E G; Watson S J; Akil H; Myers R M; Schatzberg A F; Lyons D M
Stress-induced changes in primate prefrontal profiles of gene expression.
Molecular psychiatry 2007;12(12):1089-102.
2007: Keller Martin B; Trivedi Madhukar H; Thase Michael E; Shelton Richard C; Kornstein Susan G; Nemeroff Charles B; Friedman Edward S; Gelenberg Alan J; Kocsis James H; Dunner David L; Dunlop Boadie W; Hirschfeld Robert M; Rothschild Anthony J; Ferguson James M; Schatzberg Alan F; Zajecka John M; Pedersen Ron; Yan Bing; Ahmed Saeeduddin; Schmidt Michael; Ninan Philip T
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) study: outcomes from the acute and continuation phases.
Biological psychiatry 2007;62(12):1371-9.
2007: Montgomery Stuart A; Baldwin David S; Blier Pierre; Fineberg Naomi A; Kasper Siegfried; Lader Malcolm; Lam Raymond W; Lépine Jean-Pierre; Möller Hans-Jürgen; Nutt David J; Rouillon Frederic; Schatzberg Alan F; Thase Michael E
Which antidepressants have demonstrated superior efficacy? A review of the evidence.
International clinical psychopharmacology 2007;22(6):323-9.
2007: Lyons David M; Parker Karen J; Zeitzer Jamie M; Buckmaster Christine L; Schatzberg Alan F
Preliminary evidence that hippocampal volumes in monkeys predict stress levels of adrenocorticotropic hormone.
Biological psychiatry 2007;62(10):1171-4.
2007: Ohayon Maurice M; Schatzberg Alan F
Biomarkers and classifications.
Journal of psychiatric research 2007;41(8):623-4.
2007: Buckley Theresa M; Mullen Blair C; Schatzberg Alan F
The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
Psychoneuroendocrinology 2007;32(8-10):859-64.
2007: Greicius Michael D; Flores Benjamin H; Menon Vinod; Glover Gary H; Solvason Hugh B; Kenna Heather; Reiss Allan L; Schatzberg Alan F
Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus.
Biological psychiatry 2007;62(5):429-37.
2007: Keller Martin B; Trivedi Madhukar H; Thase Michael E; Shelton Richard C; Kornstein Susan G; Nemeroff Charles B; Friedman Edward S; Gelenberg Alan J; Kocsis James H; Dunner David L; Hirschfeld Robert M A; Rothschild Anthony J; Ferguson James M; Schatzberg Alan F; Zajecka John M; Pedersen Ronald D; Yan Bing; Ahmed Saeeduddin; Musgnung Jeff; Ninan Philip T
The Prevention of Recurrent Episodes of Depression with Venlafaxine for Two Years (PREVENT) Study: Outcomes from the 2-year and combined maintenance phases.
The Journal of clinical psychiatry 2007;68(8):1246-56.
2007: Parker Karen J; Rainwater Kimberly L; Buckmaster Christine L; Schatzberg Alan F; Lindley Steven E; Lyons David M
Early life stress and novelty seeking behavior in adolescent monkeys.
Psychoneuroendocrinology 2007;32(7):785-92.
2007: Kocsis James H; Thase Michael E; Trivedi Madhukar H; Shelton Richard C; Kornstein Susan G; Nemeroff Charles B; Friedman Edward S; Gelenberg Alan J; Dunner David L; Hirschfeld Robert M A; Rothschild Anthony J; Ferguson James M; Schatzberg Alan F; Zajecka John M; Pedersen Ronald D; Yan Bing; Ahmed Saeed; Musgnung Jeff; Ninan Philip T; Keller Martin B
Prevention of recurrent episodes of depression with venlafaxine ER in a 1-year maintenance phase from the PREVENT Study.
The Journal of clinical psychiatry 2007;68(7):1014-23.
2007: Keller Jennifer; Schatzberg Alan F; Maj Mario
Current issues in the classification of psychotic major depression.
Schizophrenia bulletin 2007;33(4):877-85.
2007: O'Hara R; Schröder C M; Mahadevan R; Schatzberg A F; Lindley S; Fox S; Weiner M; Kraemer H C; Noda A; Lin X; Gray H L; Hallmayer J F
Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: association and interaction with cortisol.
Molecular psychiatry 2007;12(6):544-55.
2007: Michelson David; Adler Lenard A; Amsterdam Jay D; Dunner David L; Nierenberg Andrew A; Reimherr Frederick W; Schatzberg Alan F; Kelsey Douglas K; Williams David W
Addition of atomoxetine for depression incompletely responsive to sertraline: a randomized, double-blind, placebo-controlled study.
The Journal of clinical psychiatry 2007;68(4):582-7.
2007: Nemeroff Charles B; Kalali Amir; Keller Martin B; Charney Dennis S; Lenderts Susan E; Cascade Elisa F; Stephenson Hugo; Schatzberg Alan F
Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
Archives of general psychiatry 2007;64(4):466-72.
2007: Seeley William W; Menon Vinod; Schatzberg Alan F; Keller Jennifer; Glover Gary H; Kenna Heather; Reiss Allan L; Greicius Michael D
Dissociable intrinsic connectivity networks for salience processing and executive control.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2007;27(9):2349-56.
2007: Schatzberg Alan F
Safety and tolerability of antidepressants: weighing the impact on treatment decisions.
The Journal of clinical psychiatry 2007;68 Suppl 8():26-34.
2006: Schatzberg Alan F
New paradigm for treating recurrent depression: from symptom control to managing enduring vulnerabilities.
CNS spectrums 2006;11(12 Suppl 15):22-7.
2006: Mitra Rupshi; Sundlass Karan; Parker Karen J; Schatzberg Alan F; Lyons David M
Social stress-related behavior affects hippocampal cell proliferation in mice.
Physiology & behavior 2006;89(2):123-7.
2006: Rush A John; Kraemer Helena C; Sackeim Harold A; Fava Maurizio; Trivedi Madhukar H; Frank Ellen; Ninan Philip T; Thase Michael E; Gelenberg Alan J; Kupfer David J; Regier Darrel A; Rosenbaum Jerrold F; Ray Oakley; Schatzberg Alan F;
Report by the ACNP Task Force on response and remission in major depressive disorder.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(9):1841-53.
2006: Gomez Rowena G; Fleming Shelley H; Keller Jennifer; Flores Benjamin; Kenna Heather; DeBattista Charles; Solvason Brent; Schatzberg Alan F
The neuropsychological profile of psychotic major depression and its relation to cortisol.
Biological psychiatry 2006;60(5):472-8.
2006: Keller Jennifer; Flores Benjamin; Gomez Rowena G; Solvason H Brent; Kenna Heather; Williams Gordon H; Schatzberg Alan F
Cortisol circadian rhythm alterations in psychotic major depression.
Biological psychiatry 2006;60(3):275-81.
2006: Killen Joel D; Fortmann Stephen P; Murphy Greer M; Hayward Chris; Arredondo Christina; Cromp Deann; Celio Maria; Abe Laurie; Wang Yun; Schatzberg Alan F
Extended treatment with bupropion SR for cigarette smoking cessation.
Journal of consulting and clinical psychology 2006;74(2):286-94.
2006: Schatzberg Alan; Roose Steven
A double-blind, placebo-controlled study of venlafaxine and fluoxetine in geriatric outpatients with major depression.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2006;14(4):361-70.
2006: Karssen Adriaan M; Li Jun Z; Her Song; Patel Paresh D; Meng Fan; Evans Simon J; Vawter Marquis P; Tomita Hiroaki; Choudary Prabhakara V; Bunney William E; Jones Edward G; Watson Stanley J; Akil Huda; Myers Richard M; Schatzberg Alan F; Lyons David M
Application of microarray technology in primate behavioral neuroscience research.
Methods (San Diego, Calif.) 2006;38(3):227-34.
2006: Flores Benjamin H; Kenna Heather; Keller Jennifer; Solvason Hugh Brent; Schatzberg Alan F
Clinical and biological effects of mifepristone treatment for psychotic depression.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2006;31(3):628-36.
2006: Parker Karen J; Buckmaster Christine L; Sundlass Karan; Schatzberg Alan F; Lyons David M
Maternal mediation, stress inoculation, and the development of neuroendocrine stress resistance in primates.
Proceedings of the National Academy of Sciences of the United States of America 2006;103(8):3000-5.
2006: Keller Jennifer; Gomez Rowena G; Kenna Heather A; Poesner Joel; DeBattista Charles; Flores Benjamin; Schatzberg Alan F
Detecting psychotic major depression using psychiatric rating scales.
Journal of psychiatric research 2006;40(1):22-9.
2006: Schatzberg Alan F; Blier Pierre; Delgado Pedro L; Fava Maurizio; Haddad Peter M; Shelton Richard C
Antidepressant discontinuation syndrome: consensus panel recommendations for clinical management and additional research.
The Journal of clinical psychiatry 2006;67 Suppl 4():27-30.
2005: Nemeroff Charles B; Lieberman Jeffrey A; Weiden Peter J; Harvey Philip D; Newcomer John W; Schatzberg Alan F; Kilts Clinton D; Daniel David G
From clinical research to clinical practice: a 4-year review of ziprasidone.
CNS spectrums 2005;10(11 Suppl 17):1-20.
2005: Debattista Charles; Solomon Ari; Arnow Bruce; Kendrick Ellen; Tilston Jackie; Schatzberg Alan F
The efficacy of divalproex sodium in the treatment of agitation associated with major depression.
Journal of clinical psychopharmacology 2005;25(5):476-9.
2005: Parker Karen J; Buckmaster Christine L; Schatzberg Alan F; Lyons David M
Intranasal oxytocin administration attenuates the ACTH stress response in monkeys.
Psychoneuroendocrinology 2005;30(9):924-9.
2005: Lindley Steven E; She Xiaohong; Schatzberg Alan F
Monoamine oxidase and catechol-o-methyltransferase enzyme activity and gene expression in response to sustained glucocorticoids.
Psychoneuroendocrinology 2005;30(8):785-90.
2005: O'Hara R; Schröder C M; Kraemer H C; Kryla N; Cao C; Miller E; Schatzberg A F; Yesavage J A; Murphy G M
Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.
Neurology 2005;65(4):642-4.
2005: Roose Steven P; Schatzberg Alan F
The efficacy of antidepressants in the treatment of late-life depression.
Journal of clinical psychopharmacology 2005;25(4 Suppl 1):S1-7.
2005: Buckley Theresa M; Schatzberg Alan F
Aging and the role of the HPA axis and rhythm in sleep and memory-consolidation.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2005;13(5):344-52.
2005: Schatzberg Alan F; Rush A John; Arnow Bruce A; Banks Phillip L C; Blalock Janice A; Borian Frances E; Howland Robert; Klein Daniel N; Kocsis James H; Kornstein Susan G; Manber Rachel; Markowitz John C; Miller Ivan; Ninan Philip T; Rothbaum Barbara O; Thase Michael E; Trivedi Madhukar H; Keller Martin B
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Archives of general psychiatry 2005;62(5):513-20.
2005: Buckley Theresa M; Schatzberg Alan F
On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders.
The Journal of clinical endocrinology and metabolism 2005;90(5):3106-14.
2005: Parker Karen J; Buckmaster Christine L; Justus Katharine R; Schatzberg Alan F; Lyons David M
Mild early life stress enhances prefrontal-dependent response inhibition in monkeys.
Biological psychiatry 2005;57(8):848-55.
2005: Her Song; Patel Paresh D; Schatzberg Alan F; Lyons David M
Mutations in squirrel monkey glucocorticoid receptor impair nuclear translocation.
The Journal of steroid biochemistry and molecular biology 2005;94(4):319-26.
2005: Brannan Stephen K; Mallinckrodt Craig H; Brown Eileen B; Wohlreich Madelaine M; Watkin John G; Schatzberg Alan F
Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder.
Journal of psychiatric research 2005;39(1):43-53.
2005: Belanoff Joseph K; Sund Brenda; Koopman Cheryl; Blasey Christine; Flamm Jason; Schatzberg Alan F; Spiegel David
A randomized trial of the efficacy of group therapy in changing viral load and CD4 counts in individuals living with HIV infection.
International journal of psychiatry in medicine 2005;35(4):349-62.
2004: Murphy Greer M; Hollander Steven B; Rodrigues Heidi E; Kremer Charlotte; Schatzberg Alan F
Effects of the serotonin transporter gene promoter polymorphism on mirtazapine and paroxetine efficacy and adverse events in geriatric major depression.
Archives of general psychiatry 2004;61(11):1163-9.
2004: Killen Joel D; Robinson Thomas N; Ammerman Seth; Hayward Chris; Rogers Jayna; Samuels Deanne; Schatzberg Alan F
Major depression among adolescent smokers undergoing treatment for nicotine dependence.
Addictive behaviors 2004;29(8):1517-26.
2004: Young Elizabeth A; Altemus Margaret; Lopez Juan F; Kocsis James H; Schatzberg Alan F; DeBattista Charles; Zubieta Jon-Kar
HPA axis activation in major depression and response to fluoxetine: a pilot study.
Psychoneuroendocrinology 2004;29(9):1198-204.
2004: Posener Joel A; Charles DeBattista; Veldhuis Johannes D; Province Michael A; Williams Gordon H; Schatzberg Alan F
Process irregularity of cortisol and adrenocorticotropin secretion in men with major depressive disorder.
Psychoneuroendocrinology 2004;29(9):1129-37.
2004: Parker Karen J; Buckmaster Christine L; Schatzberg Alan F; Lyons David M
Prospective investigation of stress inoculation in young monkeys.
Archives of general psychiatry 2004;61(9):933-41.
2004: Killen Joel D; Robinson Thomas N; Ammerman Seth; Hayward Chris; Rogers Jayna; Stone Christi; Samuels Deanne; Levin Sara K; Green Sarah; Schatzberg Alan F
Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers.
Journal of consulting and clinical psychology 2004;72(4):729-35.
2004: Rothschild Anthony J; Williamson Douglas J; Tohen Mauricio F; Schatzberg Alan; Andersen Scott W; Van Campen Luann E; Sanger Todd M; Tollefson Gary D
A double-blind, randomized study of olanzapine and olanzapine/fluoxetine combination for major depression with psychotic features.
Journal of clinical psychopharmacology 2004;24(4):365-73.
2004: Lyons David M; Yang Chou; Eliez Stephan; Reiss Allan L; Schatzberg Alan F
Cognitive correlates of white matter growth and stress hormones in female squirrel monkey adults.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2004;24(14):3655-62.
2004: Fleming Shelley K; Blasey Christine; Schatzberg Alan F
Neuropsychological correlates of psychotic features in major depressive disorders: a review and meta-analysis.
Journal of psychiatric research 2004;38(1):27-35.
2004: Schatzberg Alan F
Non-schizophrenic psychoses: common and distinguishing features.
Journal of psychiatric research 2004;38(1):1-2.
2004: Schatzberg Alan F
Employing pharmacologic treatment of bipolar disorder to greatest effect.
The Journal of clinical psychiatry 2004;65 Suppl 15():15-20.
2004: Schatzberg Alan F
The relationship of chronic pain and depression.
The Journal of clinical psychiatry 2004;65 Suppl 12():3-4.
2004: Schatzberg Alan F
Pharmacologic treatments of major depression: are two mechanisms really better than one?
The Journal of clinical psychiatry 2004;65 Suppl 4():3-4.
2003: Nemeroff Charles B; Heim Christine M; Thase Michael E; Klein Daniel N; Rush A John; Schatzberg Alan F; Ninan Philip T; McCullough James P; Weiss Paul M; Dunner David L; Rothbaum Barbara O; Kornstein Susan; Keitner Gabor; Keller Martin B
Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma.
Proceedings of the National Academy of Sciences of the United States of America 2003;100(24):14293-6.
2003: Murphy Greer M; Kremer Charlotte; Rodrigues Heidi E; Schatzberg Alan F
Pharmacogenetics of antidepressant medication intolerance.
The American journal of psychiatry 2003;160(10):1830-5.
2003: Murphy Greer M; Kremer Charlotte; Rodrigues Heidi; Schatzberg Alan F;
The apolipoprotein E epsilon4 allele and antidepressant efficacy in cognitively intact elderly depressed patients.
Biological psychiatry 2003;54(7):665-73.
2003: Boyett-Anderson J M; Lyons D M; Reiss A L; Schatzberg A F; Menon V
Functional brain imaging of olfactory processing in monkeys.
NeuroImage 2003;20(1):257-64.
2003: Lyons David M; Schatzberg Alan F
Early maternal availability and prefrontal correlates of reward-related memory.
Neurobiology of learning and memory 2003;80(2):97-104.
2003: Killen Joel D; Fortmann Stephen P; Schatzberg Alan; Hayward Chris; Varady Ann
Onset of major depression during treatment for nicotine dependence.
Addictive behaviors 2003;28(3):461-70.
2003: Mallick Rajiv; Chen Jieling; Entsuah A Richard; Schatzberg Alan F
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.
The Journal of clinical psychiatry 2003;64(3):321-30.
2003: DeBattista Charles; Solvason H Brent; Poirier Jennifer; Kendrick Ellen; Schatzberg Alan F
A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.
Journal of clinical psychopharmacology 2003;23(1):27-30.
2003: Parker Karen J; Schatzberg Alan F; Lyons David M
Neuroendocrine aspects of hypercortisolism in major depression.
Hormones and behavior 2003;43(1):60-6.
2003: Ohayon Maurice M; Schatzberg Alan F
Using chronic pain to predict depressive morbidity in the general population.
Archives of general psychiatry 2003;60(1):39-47.
2003: Schatzberg Alan F
Introduction: treating depression and anxiety to remission.
The Journal of clinical psychiatry 2003;64 Suppl 15():3-4.
2003: Schatzberg Alan F
Efficacy and tolerability of duloxetine, a novel dual reuptake inhibitor, in the treatment of major depressive disorder.
The Journal of clinical psychiatry 2003;64 Suppl 13():30-7.
2003: Schatzberg Alan F
New approaches to managing psychotic depression.
The Journal of clinical psychiatry 2003;64 Suppl 1():19-23.
2003: Greicius Michael D; Krasnow Ben; Boyett-Anderson Jesse M; Eliez Stephan; Schatzberg Alan F; Reiss Allan L; Menon Vinod
Regional analysis of hippocampal activation during memory encoding and retrieval: fMRI study.
Hippocampus 2003;13(1):164-74.
2002: Lindley Steven E; Bengoechea Tasha G; Wong Dona L; Schatzberg Alan F
Mesotelencephalic dopamine neurochemical responses to glucocorticoid administration and adrenalectomy in Fischer 344 and Lewis rats.
Brain research 2002;958(2):414-22.
2002: Ohayon Maurice M; Schatzberg Alan F
Prevalence of depressive episodes with psychotic features in the general population.
The American journal of psychiatry 2002;159(11):1855-61.
2002: Schatzberg Alan F
Brain imaging in affective disorders: more questions about causes versus effects.
The American journal of psychiatry 2002;159(11):1807-8.
2002: Lyons David M; Afarian Hagop; Schatzberg Alan F; Sawyer-Glover Anne; Moseley Michael E
Experience-dependent asymmetric variation in primate prefrontal morphology.
Behavioural brain research 2002;136(1):51-9.
2002: Tamminga Carol A; Nemeroff Charles B; Blakely Randy D; Brady Linda; Carter Cameron S; Davis Kenneth L; Dingledine Raymond; Gorman Jack M; Grigoriadis Dimitri E; Henderson David C; B Innis Robert B; Killen John; Laughren Thomas P; McDonald William M; M Murphy Greer M; Paul Steven M; Rudorfer Matthew V; Sausville Edward; Schatzberg Alan F; Scolnick Edward M; Suppes Trisha
Developing novel treatments for mood disorders: accelerating discovery.
Biological psychiatry 2002;52(6):589-609.
2002: Belanoff Joseph K; Rothschild Anthony J; Cassidy Frederick; DeBattista Charles; Baulieu Etienne-Emile; Schold Clifford; Schatzberg Alan F
An open label trial of C-1073 (mifepristone) for psychotic major depression.
Biological psychiatry 2002;52(5):386-92.
2002: Schatzberg Alan F; Kremer Charlotte; Rodrigues Heidi E; Murphy Greer M;
Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2002;10(5):541-50.
2002: Belanoff Joseph K; Jurik Jennifer; Schatzberg Lindsey D; DeBattista Charles; Schatzberg Alan F
Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone.
Journal of molecular neuroscience : MN 2002;19(1-2):201-6.
2002: Kocsis James H; Schatzberg Alan; Rush A John; Klein Daniel N; Howland Robert; Gniwesch Leah; Davis Sonia M; Harrison Wilma
Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
Archives of general psychiatry 2002;59(8):723-8.
2002: Kupfer David J; Hyman Steven E; Schatzberg Alan F; Pincus Harold A; Reynolds Charles F
Recruiting and retaining future generations of physician scientists in mental health.
Archives of general psychiatry 2002;59(7):657-60.
2002: Schatzberg Alan F
Pharmacological principles of antidepressant efficacy.
Human psychopharmacology 2002;17 Suppl 1():S17-22.
2002: Thase Michael E; Rush A John; Manber Rachel; Kornstein Susan G; Klein Daniel N; Markowitz John C; Ninan Philip T; Friedman Edward S; Dunner David L; Schatzberg Alan F; Borian Frances E; Trivedi Madhukar H; Keller Martin B
Differential effects of nefazodone and cognitive behavioral analysis system of psychotherapy on insomnia associated with chronic forms of major depression.
The Journal of clinical psychiatry 2002;63(6):493-500.
2002: Menon Vinod; Boyett-Anderson Jesse M; Schatzberg Alan F; Reiss Allan L
Relating semantic and episodic memory systems.
Brain research. Cognitive brain research 2002;13(2):261-5.
2002: Thase Michael E; Rush A John; Howland Robert H; Kornstein Susan G; Kocsis James H; Gelenberg Alan J; Schatzberg Alan F; Koran Lorrin M; Keller Martin B; Russell James M; Hirschfeld Robert M A; LaVange Lisa M; Klein Daniel N; Fawcett Jan; Harrison Wilma
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
Archives of general psychiatry 2002;59(3):233-9.
2002: Hirschfeld Robert M A; Dunner David L; Keitner Gabor; Klein Daniel N; Koran Lorrin M; Kornstein Susan G; Markowitz John C; Miller Ivan; Nemeroff Charles B; Ninan Philip T; Rush A John; Schatzberg Alan F; Thase Michael E; Trivedi Madhukar H; Borian Frances E; Crits-Christoph Paul; Keller Martin B
Does psychosocial functioning improve independent of depressive symptoms? A comparison of nefazodone, psychotherapy, and their combination.
Biological psychiatry 2002;51(2):123-33.
2002: Nemeroff Charles B; Schatzberg Alan F; Goldstein David J; Detke Michael J; Mallinckrodt Craig; Lu Yili; Tran Pierre V
Duloxetine for the treatment of major depressive disorder.
Psychopharmacology bulletin 2002;36(4):106-32.
2002: McDonald William M; Salzman Carl; Schatzberg Alan F
Depression in the elderly.
Psychopharmacology bulletin 2002;36 Suppl 2():112-22.
2002: Schatzberg Alan F; Prather Maureen R; Keller Martin B; Rush A John; Laird Lyle K; Wright Clinton W
Clinical use of nefazodone in major depression: a 6-year perspective.
The Journal of clinical psychiatry 2002;63 Suppl 1():18-31.
2001: Lyons D M; Yang C; Sawyer-Glover A M; Moseley M E; Schatzberg A F
Early life stress and inherited variation in monkey hippocampal volumes.
Archives of general psychiatry 2001;58(12):1145-51.
2001: Posener J A; DeBattista C; Williams G H; Schatzberg A F
Cortisol feedback during the HPA quiescent period in patients with major depression.
The American journal of psychiatry 2001;158(12):2083-5.
2001: Claassen J D; Pascoe N; Schatzberg A F; Murphy G M
Rapid detection of the C-1496G polymorphism in the CYP2D6 *2 allele.
Clinical chemistry 2001;47(12):2153-5.
2001: Belanoff J K; Flores B H; Kalezhan M; Sund B; Schatzberg A F
Rapid reversal of psychotic depression using mifepristone.
Journal of clinical psychopharmacology 2001;21(5):516-21.
2001: Belanoff J K; Kalehzan M; Sund B; Fleming Ficek S K; Schatzberg A F
Cortisol activity and cognitive changes in psychotic major depression.
The American journal of psychiatry 2001;158(10):1612-6.
2001: Chu J W; Matthias D F; Belanoff J; Schatzberg A; Hoffman A R; Feldman D
Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486).
The Journal of clinical endocrinology and metabolism 2001;86(8):3568-73.
2001: Koran L M; Gelenberg A J; Kornstein S G; Howland R H; Friedman R A; DeBattista C; Klein D; Kocsis J H; Schatzberg A F; Thase M E; Rush A J; Hirschfeld R M; LaVange L M; Keller M B
Sertraline versus imipramine to prevent relapse in chronic depression.
Journal of affective disorders 2001;65(1):27-36.
2001: Belanoff J K; Gross K; Yager A; Schatzberg A F
Corticosteroids and cognition.
Journal of psychiatric research 2001;35(3):127-45.
2000: Patel P D; Lopez J F; Lyons D M; Burke S; Wallace M; Schatzberg A F
Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain.
Journal of psychiatric research 2000;34(6):383-92.
2000: Killen J D; Fortmann S P; Schatzberg A F; Hayward C; Sussman L; Rothman M; Strausberg L; Varady A
Nicotine patch and paroxetine for smoking cessation.
Journal of consulting and clinical psychology 2000;68(5):883-9.
2000: Lyons D M; Lopez J M; Yang C; Schatzberg A F
Stress-level cortisol treatment impairs inhibitory control of behavior in monkeys.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2000;20(20):7816-21.
2000: Kornstein S G; Schatzberg A F; Thase M E; Yonkers K A; McCullough J P; Keitner G I; Gelenberg A J; Ryan C E; Hess A L; Harrison W; Davis S M; Keller M B
Gender differences in chronic major and double depression.
Journal of affective disorders 2000;60(1):1-11.
2000: Kornstein S G; Schatzberg A F; Thase M E; Yonkers K A; McCullough J P; Keitner G I; Gelenberg A J; Davis S M; Harrison W M; Keller M B
Gender differences in treatment response to sertraline versus imipramine in chronic depression.
The American journal of psychiatry 2000;157(9):1445-52.
2000: Lyons D M; Yang C; Mobley B W; Nickerson J T; Schatzberg A F
Early environmental regulation of glucocorticoid feedback sensitivity in young adult monkeys.
Journal of neuroendocrinology 2000;12(8):723-8.
2000: Posener J A; DeBattista C; Williams G H; Chmura Kraemer H; Kalehzan B M; Schatzberg A F
24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression.
Archives of general psychiatry 2000;57(8):755-60.
2000: DeBattista C; Posener J A; Kalehzan B M; Schatzberg A F
Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study.
The American journal of psychiatry 2000;157(8):1334-7.
2000: Schatzberg A F; Posener J A; DeBattista C; Kalehzan B M; Rothschild A J; Shear P K
Neuropsychological deficits in psychotic versus nonpsychotic major depression and no mental illness.
The American journal of psychiatry 2000;157(7):1095-100.
2000: Hayward C; Varady S; Albano A M; Thienemann M; Henderson L; Schatzberg A F
Cognitive-behavioral group therapy for social phobia in female adolescents: results of a pilot study.
Journal of the American Academy of Child and Adolescent Psychiatry 2000;39(6):721-6.
2000: Hirschfeld R M; Montgomery S A; Keller M B; Kasper S; Schatzberg A F; Möller H J; Healy D; Baldwin D; Humble M; Versiani M; Montenegro R; Bourgeois M
Social functioning in depression: a review.
The Journal of clinical psychiatry 2000;61(4):268-75.
2000: Schatzberg A F; Kraemer H C
Use of placebo control groups in evaluating efficacy of treatment of unipolar major depression.
Biological psychiatry 2000;47(8):736-44.
2000: DeBattista C; Solvason H B; Breen J A; Schatzberg A F
Pramipexole augmentation of a selective serotonin reuptake inhibitor in the treatment of depression.
Journal of clinical psychopharmacology 2000;20(2):274-5.
2000: Patel P D; Lyons D M; Zhang Z; Ngo H; Schatzberg A F
Impaired transactivation of the glucocorticoid receptor cloned from the Guyanese squirrel monkey.
The Journal of steroid biochemistry and molecular biology 2000;72(3-4):115-23.
2000: Tolwani R J; Waggie K S; Green S L; Tolwani A J; Lyons D M; Schatzberg A F
Dilative cardiomyopathy leading to congestive heart failure in a male squirrel monkey (Saimiri sciureus).
Journal of medical primatology 2000;29(1):42-5.
2000: Schatzberg A F
New indications for antidepressants.
The Journal of clinical psychiatry 2000;61 Suppl 11():9-17.
2000: Schatzberg A F
Clinical efficacy of reboxetine in major depression.
The Journal of clinical psychiatry 2000;61 Suppl 10():31-8.
1999: Lyons D M; Martel F L; Levine S; Risch N J; Schatzberg A F
Postnatal experiences and genetic effects on squirrel monkey social affinities and emotional distress.
Hormones and behavior 1999;36(3):266-75.
1999: Klein D N; Schatzberg A F; McCullough J P; Dowling F; Goodman D; Howland R H; Markowitz J C; Smith C; Thase M E; Rush A J; LaVange L; Harrison W M; Keller M B
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response.
Journal of affective disorders 1999;55(2-3):149-57.
1999: Lindley S E; Bengoechea T G; Schatzberg A F; Wong D L
Glucocorticoid effects on mesotelencephalic dopamine neurotransmission.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(3):399-407.
1999: Lindley S E; Bengoechea T G; Wong D L; Schatzberg A F
Strain differences in mesotelencephalic dopaminergic neuronal regulation between Fischer 344 and Lewis rats.
Brain research 1999;832(1-2):152-8.
1999: Lyons D M; Wang O J; Lindley S E; Levine S; Kalin N H; Schatzberg A F
Separation induced changes in squirrel monkey hypothalamic-pituitary-adrenal physiology resemble aspects of hypercortisolism in humans.
Psychoneuroendocrinology 1999;24(2):131-42.
1999: Klein D N; Schatzberg A F; McCullough J P; Keller M B; Dowling F; Goodman D; Howland R H; Markowitz J C; Smith C; Miceli R; Harrison W M
Early- versus late-onset dythymic disorder: comparison in out-patients with superimposed major depressive episodes.
Journal of affective disorders 1999;52(1-3):187-96.
1999: Martel F L; Hayward C; Lyons D M; Sanborn K; Varady S; Schatzberg A F
Salivary cortisol levels in socially phobic adolescent girls.
Depression and anxiety 1999;10(1):25-7.
1999: Schatzberg A F; DeBattista C
Phenomenology and treatment of agitation.
The Journal of clinical psychiatry 1999;60 Suppl 15():17-20.
1999: Schatzberg A F
Antidepressant effectiveness in severe depression and melancholia.
The Journal of clinical psychiatry 1999;60 Suppl 4():14-21; discussion 22.
1998: Miller I W; Keitner G I; Schatzberg A F; Klein D N; Thase M E; Rush A J; Markowitz J C; Schlager D S; Kornstein S G; Davis S M; Harrison W M; Keller M B
The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine.
The Journal of clinical psychiatry 1998;59(11):608-19.
1998: Rush A J; Koran L M; Keller M B; Markowitz J C; Harrison W M; Miceli R J; Fawcett J A; Gelenberg A J; Hirschfeld R M; Klein D N; Kocsis J H; McCullough J P; Schatzberg A F; Thase M E
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies.
The Journal of clinical psychiatry 1998;59(11):589-97.
1998: Keller M B; Kocsis J H; Thase M E; Gelenberg A J; Rush A J; Koran L; Schatzberg A; Russell J; Hirschfeld R; Klein D; McCullough J P; Fawcett J A; Kornstein S; LaVange L; Harrison W
Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1998;280(19):1665-72.
1998: DeBattista C; Sofuoglu M; Schatzberg A F
Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs.
Biological psychiatry 1998;44(5):341-7.
1998: Lyons D M; Kim S; Schatzberg A F; Levine S
Postnatal foraging demands alter adrenocortical activity and psychosocial development.
Developmental psychobiology 1998;32(4):285-91.
1998: Schatzberg A F; Samson J A; Rothschild A J; Bond T C; Regier D A
McLean Hospital depression research facility: early-onset phobic disorders and adult-onset major depression.
The British journal of psychiatry. Supplement 1998;(34):29-34.
1998: Schatzberg A F
Noradrenergic versus serotonergic antidepressants: predictors of treatment response.
The Journal of clinical psychiatry 1998;59 Suppl 14():15-8.
1998: Schatzberg A F
Bipolar disorder: recent issues in diagnosis and classification.
The Journal of clinical psychiatry 1998;59 Suppl 6():5-10; discussion 11-2.
1997: Debattista C; Solvason H B; Belanoff J; Schatzberg A F
Treatment of psychotic depression.
The American journal of psychiatry 1997;154(11):1625-6.
1997: Schatzberg A F
The dynamics of sex: gender differences in psychiatric disorders.
The Journal of clinical psychiatry 1997;58 Suppl 15():3-4.
1997: Schatzberg A F; Haddad P; Kaplan E M; Lejoyeux M; Rosenbaum J F; Young A H; Zajecka J
Possible biological mechanisms of the serotonin reuptake inhibitor discontinuation syndrome. Discontinuation Consensus Panel.
The Journal of clinical psychiatry 1997;58 Suppl 7():23-7.
1997: Schatzberg A F; Haddad P; Kaplan E M; Lejoyeux M; Rosenbaum J F; Young A H; Zajecka J
Serotonin reuptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation Consensus panel.
The Journal of clinical psychiatry 1997;58 Suppl 7():5-10.
1996: Posener J A; Schildkraut J J; Samson J A; Schatzberg A F
Diurnal variation of plasma cortisol and homovanillic acid in healthy subjects.
Psychoneuroendocrinology 1996;21(1):33-8.
1995: Debattista C; Schatzberg A F
Physical symptoms associated with paroxetine withdrawal.
The American journal of psychiatry 1995;152(8):1235-4.
1995: Salzman C; Wolfson A N; Schatzberg A; Looper J; Henke R; Albanese M; Schwartz J; Miyawaki E
Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder.
Journal of clinical psychopharmacology 1995;15(1):23-9.
1995: Kornstein S G; Schatzberg A F; Yonkers K A; Thase M E; Keitner G I; Ryan C E; Schlager D
Gender differences in presentation of chronic major depression.
Psychopharmacology bulletin 1995;31(4):711-8.
1995: Keller M B; Harrison W; Fawcett J A; Gelenberg A; Hirschfeld R M; Klein D; Kocsis J H; McCullough J P; Rush A J; Schatzberg A
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.
Psychopharmacology bulletin 1995;31(2):205-12.
1994: Posener J A; Schildkraut J J; Williams G H; Gleason R E; Salomon M S; Mecheri G; Schatzberg A F
Acute and delayed effects of corticotropin-releasing hormone on dopamine activity in man.
Biological psychiatry 1994;36(9):616-21.
1994: Albanese M J; Bartel R L; Bruno R F; Morgenbesser M W; Schatzberg A F
Comparison of measures used to determine substance abuse in an inpatient psychiatric population.
The American journal of psychiatry 1994;151(7):1077-8.
1993: Bowden C L; Schatzberg A F; Rosenbaum A; Contreras S A; Samson J A; Dessain E; Sayler M
Fluoxetine and desipramine in major depressive disorder.
Journal of clinical psychopharmacology 1993;13(5):305-11.
1993: Rothschild A J; Samson J A; Bond T C; Luciana M M; Schildkraut J J; Schatzberg A F
Hypothalamic-pituitary-adrenal axis activity and 1-year outcome in depression.
Biological psychiatry 1993;34(6):392-400.
1993: Green A I; Alam M Y; Sobieraj J T; Pappalardo K M; Waternaux C; Salzman C; Schatzberg A F; Schildkraut J J
Clozapine response and plasma catecholamines and their metabolites.
Psychiatry research 1993;46(2):139-49.
1992: Schatzberg A F; Rothschild A J
Serotonin activity in psychotic (delusional) major depression.
The Journal of clinical psychiatry 1992;53 Suppl():52-5.
1992: Schatzberg A F; Rothschild A J
Psychotic (delusional) major depression: should it be included as a distinct syndrome in DSM-IV?
The American journal of psychiatry 1992;149(6):733-45.
1992: Schatzberg A F
Recent developments in the acute somatic treatment of major depression.
The Journal of clinical psychiatry 1992;53 Suppl():20-5.
1992: Schildkraut J J; Schatzberg A F; Samson J A; Rosenbaum A; Bowden C L
Norepinephrine output and metabolism in depressed patients during antidepressant treatments.
Clinical neuropharmacology 1992;15 Suppl 1 Pt A():323A-324A.
1991: Mooney J J; Schatzberg A F; Cole J O; Samson J A; Waternaux C; Gerson B; Pappalardo K M; Schildkraut J J
Urinary 3-methoxy-4-hydroxyphenylglycol and the depression-type score as predictors of differential responses to antidepressants.
Journal of clinical psychopharmacology 1991;11(6):339-43.
1991: Schatzberg A F
Overview of anxiety disorders: prevalence, biology, course, and treatment.
The Journal of clinical psychiatry 1991;52 Suppl():5-9.
1991: Schatzberg A F
Dosing strategies for antidepressant agents.
The Journal of clinical psychiatry 1991;52 Suppl():14-20.
1991: Schatzberg A F; Ballenger J C
Decisions for the clinician in the treatment of panic disorder: when to treat, which treatment to use, and how long to treat.
The Journal of clinical psychiatry 1991;52 Suppl():26-31; discussion 32.
1990: Schatzberg A F; Samson J A; Rothschild A J; Luciana M M; Bruno R F; Bond T C
Depression secondary to anxiety: findings from the McLean Hospital Depression Research Facility.
The Psychiatric clinics of North America 1990;13(4):633-49.
1990: Schatzberg A F
Anxiety and adjustment disorder: a treatment approach.
The Journal of clinical psychiatry 1990;51 Suppl():20-4.
1990: Schatzberg A F
Benzodiazepines: therapeutic, biological, and psychosocial issues.
Journal of psychiatric research 1990;24 Suppl 2():1-2.
1989: Rothschild A J; Benes F; Hebben N; Woods B; Luciana M; Bakanas E; Samson J A; Schatzberg A F
Relationships between brain CT scan findings and cortisol in psychotic and nonpsychotic depressed patients.
Biological psychiatry 1989;26(6):565-75.
1989: Schatzberg A F; Samson J A; Bloomingdale K L; Orsulak P J; Gerson B; Kizuka P P; Cole J O; Schildkraut J J
Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders.
Archives of general psychiatry 1989;46(3):260-8.
1988: Mooney J J; Schatzberg A F; Cole J O; Kizuka P P; Salomon M; Lerbinger J; Pappalardo K M; Gerson B; Schildkraut J J
Rapid antidepressant response to alprazolam in depressed patients with high catecholamine output and heterologous desensitization of platelet adenylate cyclase.
Biological psychiatry 1988;23(6):543-59.
1988: Schatzberg A F; Rothschild A J
The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression.
Annals of the New York Academy of Sciences 1988;537():462-71.
1987: Schatzberg A F; Dessain E; O'Neil P; Katz D L; Cole J O
Recent studies on selective serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
Journal of clinical psychopharmacology 1987;7(6 Suppl):44S-49S.
1987: Schatzberg A F; Rothschild A J; Langlais P J; Lerbinger J E; Schildkraut J J; Cole J O
Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms.
Psychiatry research 1987;20(2):155-64.
1987: Rothschild A J; Schatzberg A F; Langlais P J; Lerbinger J E; Miller M M; Cole J O
Psychotic and nonpsychotic depressions: I. Comparison of plasma catecholamines and cortisol measures.
Psychiatry research 1987;20(2):143-53.
1986: Bond T C; Rothschild A J; Lerbinger J; Schatzberg A F
Delusional depression, family history, and DST response: a pilot study.
Biological psychiatry 1986;21(13):1239-46.
1986: Dessain E C; Schatzberg A F; Woods B T; Cole J O
Maprotiline treatment in depression. A perspective on seizures.
Archives of general psychiatry 1986;43(1):86-90.
1985: Rothschild A J; Langlais P J; Schatzberg A F; Miller M M; Saloman M S; Lerbinger J E; Cole J O; Bird E D
The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain.
Life sciences 1985;36(26):2491-501.
1985: Schatzberg A F; Rothschild A J; Gerson B; Lerbinger J E; Schildkraut J J
Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
The British journal of psychiatry : the journal of mental science 1985;146():633-7.
1985: Mooney J J; Cole J O; Schatzberg A F; Gerson B; Schildkraut J J
Pretreatment urinary MHPG levels as predictors of antidepressant responses to alprazolam.
The American journal of psychiatry 1985;142(3):366-7.
1985: Samson J A; Gudeman J E; Schatzberg A F; Kizuka P P; Orsulak P J; Cole J O; Schildkraut J J
Toward a biochemical classification of depressive disorders--VIII. Platelet monoamine oxidase activity in subtypes of depressions.
Journal of psychiatric research 1985;19(4):547-55.
1985: Mooney J J; Schatzberg A F; Cole J O; Kizuka P P; Schildkraut J J
Enhanced signal transduction by adenylate cyclase in platelet membranes of patients showing antidepressant responses to alprazolam: preliminary data.
Journal of psychiatric research 1985;19(1):65-75.
1985: Schatzberg A F; Rothschild A J; Langlais P J; Bird E D; Cole J O
A corticosteroid/dopamine hypothesis for psychotic depression and related states.
Journal of psychiatric research 1985;19(1):57-64.
1984: Rosenbaum A H; Schatzberg A F; MacLaughlin R A; Snyder K; Jiang N S; Ilstrup D; Rothschild A J; Kliman B
The dexamethasone suppression test in normal control subjects: comparison of two assays and effect of age.
The American journal of psychiatry 1984;141(12):1550-5.
1984: Rothschild A J; Langlais P J; Schatzberg A F; Walsh F X; Cole J O; Bird E D
Dexamethasone increases plasma free dopamine in man.
Journal of psychiatric research 1984;18(3):217-23.
1984: Schatzberg A F; Rothschild A J; Bond T C; Cole J O
The DST in psychotic depression: diagnostic and pathophysiologic implications.
Psychopharmacology bulletin 1984;20(3):362-4.
1983: Schatzberg A F; Orsulak P J; Rothschild A J; Salomon M S; Lerbinger J; Kizuka P P; Cole J O; Schildkraut J J
Platelet MAO activity and the dexamethasone suppression test in depressed patients.
The American journal of psychiatry 1983;140(9):1231-3.
1983: Rosenbaum A H; Maruta T; Schatzberg A F; Orsulak P J; Jiang N S; Cole J O; Schildkraut J J
Toward a biochemical classification of depressive disorders, VII: urinary free cortisol and urinary MHPG in depressions.
The American journal of psychiatry 1983;140(3):314-8.
1983: Schatzberg A F; Rothschild A J; Stahl J B; Bond T C; Rosenbaum A H; Lofgren S B; MacLaughlin R A; Sullivan M A; Cole J O
The dexamethasone suppression test: identification of subtypes of depression.
The American journal of psychiatry 1983;140(1):88-91.
1982: Rothschild A J; Schatzberg A F; Rosenbaum A H; Stahl J B; Cole J O
The dexamethasone suppression test as a discriminator among subtypes of psychotic patients.
The British journal of psychiatry : the journal of mental science 1982;141():471-4.
1982: Gudeman J E; Schatzberg A F; Samson J A; Orsulak P J; Cole J O; Schildkraut J J
Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.
The American journal of psychiatry 1982;139(5):630-3.
1982: Schatzberg A F; Orsulak P J; Rosenbaum A H; Maruta T; Kruger E R; Cole J O; Schildkraut J J
Toward a biochemical classification of depressive disorders, V: Heterogeneity of unipolar depressions.
The American journal of psychiatry 1982;139(4):471-5.
1981: Schildkraut J J; Orsulak P J; Schatzberg A F; Cole J O; Rosenbaum A H
Possible pathophysiological mechanisms in subtypes of unipolar depressive disorders based on differences in urinary MHPG levels [proceedings]
Psychopharmacology bulletin 1981;17(1):90-91.
1981: Schatzberg A F; Rosenbaum A H; Orsulak P J; Rohde W A; Maruta T; Kruger E R; Cole J O; Schildkraut J J
Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline.
Psychopharmacology 1981;75(1):34-8.
1980: Schatzberg A F; Orsulak P J; Rosenbaum A H; Kruger E R; Schildkraut J J; Cole J O
Catecholamine measures for diagnosis and treatment of patients with depressive disorders.
The Journal of clinical psychiatry 1980;41(12 Pt 2):35-9.
1980: Rosenbaum A H; Schatzberg A F; Maruta T; Orsulak P J; Cole J O; Grab E L; Schildkraut J J
MHPG as a predictor of antidepressant response to imipramine and maprotiline.
The American journal of psychiatry 1980;137(9):1090-2.
1980: Schatzberg A F; Orsulak P J; Rosenbaum A H; Maruta T; Kruger E R; Cole J O; Schildkraut J J
Toward a biochemical classification of depressive disorders IV: Pretreatment urinary MHPG levels as predictors of antidepressant response to imipramine.
Communications in psychopharmacology 1980;4(5):441-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Alan Schatzberg

Research Profile (preview)

Disorders

Chemicals & Drugs

Concepts & Ideas

Living Beings

Procedures

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Alan Schatzberg (preview)

All Publications